Trials
1 active
6 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Gout, Gouty Arthritis, Hyperuricemia, Gout Chronic, Refractory Gout, Uncontrolled Gout, Tophaceous Gout
- Main trialPhase 2
- “This study will assess the effect of AR882 and XOI co-administration on sUA lowering as well as reducing tophus burden in the population that has failed uricase treatment (eg., pegloticase). Failed uricase treatment is defined as having an inherent intolerance, anaphylaxis, infusion reaction, antibody development, and/or at least one sUA level that rose to greater than 6 mg/dL while on therapy.”In the company’s words, NCT07116746 on ClinicalTrials.gov
Other drugs for Gout
- DapansutrileOlatec Therapeutics, Inc. · Phase 2/3
- EtoricoxibLaboratorios Silanes S.A. de C.V. · Phase 3
- DotinuradCrystalys Therapeutics · Phase 3
- SSGJ-6133SBio · Phase 2
- PRX-115Protalix · Phase 2
- BR2251BioRay Pharmaceutical Co., Ltd. · Phase 2
Coming up1
- NovPhase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Active, not recruiting | Nov 2026 | Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients | |
| Phase 3Completed | 20 Mar 2026 | Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) | |
| Phase 3Completed | 31 Aug 2026 | Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) | |
| Phase 2Completed | 17 Nov 2022 | Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients | |
| Phase 2Completed | 13 Aug 2024 | Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout | |
| Phase 1Completed | 27 Jun 2022 | Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026